TWINSBURG, Ohio, July 8, 2019 /PRNewswire/ -- Edgepark Medical Supplies ("Edgepark") recently learned about a security incident that may have impacted some personal information of a small percentage of our Edgepark.com customers.  On or about May 13, 2019, Edgepark learned that the shipping address listed in a small number o

NEW YORK, July 8, 2019 /PRNewswire/ -- Zeel, the Massage On Demand® company and global wellness brand, announced today that Nacho Figueras, world-renowned polo player and long-time face of Ralph Lauren, will be joining the company as a Brand Ambassador alongside his wife, photographer and model, Delfina Blaquier. 

SPRINGFIELD, Mo., July 8, 2019 /PRNewswire/ -- The TrustHCS Coding Academy has recently been approved as an eligible training provider, according to the Workforce Innovation and Opportunity Act (WIOA) in Missouri. With this eligibility, the State of Missouri will pay for the enrollment and tuition of approved students in the

RA'ANANA, Israel, July 8, 2019 /PRNewswire/ -- MedAware (www.medaware.com), a developer of AI-based patient safety solutions, announced today the appointment of Dr. John Halamka, MD, MS, as its newest scientific advisory board member. Dr. Halamka currently serves a

SEATTLE, July 8, 2019 /PRNewswire/ -- The Kois Center (https://www.koiscenter.co

BALTIMORE, July 8, 2019 /PRNewswire/ -- Who: The Oxford Club is a private, international network of trustworthy and knowledgeable investors and entrepreneurs with a mission to help members grow and protect their wealth. What: The 2019 American Health & Wealth Summit streamed online event, hosted by The Oxford Club, will feature former speake

SOUTH SAN FRANCISCO, Calif., July 8, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new in vitro data establishing the relationship between concentrations of the direct oral anticoagulants (DOACs) apixaban and rivaroxaban and the ability of four-factor prothrombin complex concentrate (4F-PCC) to correct inh

RARITAN, N.J., July 8, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged birth to 17 years) treated with XARELTO® (rivaroxaban) had a similar low risk of recurrent venous thromboembolism (VTE) – or blood clots –

SAN DIEGO and ZUG, Switzerland, July 8, 2019 /PRNewswire/ -- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and SQ Innovation AG today announced that the two companies have entered into long-term, exclusive commercial license and supply agreements for use of Ligand's Captisol® technology in the formulation o

TUCSON, Ariz., July 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the second quarter of 2019 after the market close on Thursday, August 8, 2019. The company's management will host a conference call at 4:30 p.m. ET that same day